117 filings
Page 4 of 6
8-K
gj5iqb ue
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
8vakv38jajbd oa9r0
14 May 21
Additional proxy soliciting materials
4:05pm
8-K
x011lmt9bc7uu25vhp
12 May 21
Amwell® Announces Results for First Quarter 2021
4:10pm
DEFA14A
w3hmkm1qc4gv 17lg3
30 Apr 21
Additional proxy soliciting materials
4:09pm
DEF 14A
81h9s
30 Apr 21
Definitive proxy
4:05pm
10-K
fu0v702259obnapb t15
26 Mar 21
Annual report
4:02pm
8-K
ukuz3cv yb4w
24 Mar 21
Amwell® Announces Results for Fourth Quarter and Full Year 2020
4:16pm
424B4
c79 zyddlfiaq
15 Jan 21
Prospectus supplement with pricing info
4:21pm
EFFECT
6vbfgk
15 Jan 21
Notice of effectiveness
12:15am
8-K
wp23sj9y
12 Jan 21
Results of Operations and Financial Condition
4:41pm
CORRESP
hh8jx1gmh093h6m951
12 Jan 21
Correspondence with SEC
12:00am
CORRESP
uclnst rp
12 Jan 21
Correspondence with SEC
12:00am
UPLOAD
4h2zrab5pefx 1iq4j
11 Jan 21
Letter from SEC
12:00am
DRS
ng6riwhtbup44ya
6 Jan 21
Draft registration statement
12:00am
10-Q
s3h2rj
13 Nov 20
Quarterly report
4:07pm
8-K
bgt8xro 8ax0o1134px
12 Nov 20
Amwell® Announces Results for Third Quarter 2020
4:28pm
8-K
jytuz god
9 Oct 20
Amwell Announces Appointment of Deborah C. Jackson to its Board of Directors
11:35am
8-K
326cuw nwa6
22 Sep 20
Amwell Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
8:39am